Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=220"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=220

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00336284-sae",
        "title": "Home Monitoring vs Conventional: serious adverse events",
        "summary": "124 of 977 against 74 of 473; risk difference -3.0 points, 95% interval -7.0 to 0.8; NCT00336284, TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up",
        "record": "/library/comparisons/NCT00336284-sae",
        "nct_id": "NCT00336284",
        "kind": "serious-adverse-events",
        "participants": 1450,
        "risk_difference": {
          "value": -0.02952906273465175,
          "lower": -0.06998720274690237,
          "upper": 0.007842667473756178
        },
        "group_1": "124 of 977",
        "group_2": "74 of 473",
        "difference": "-3.0 points",
        "interval": "-7.0 to 0.8",
        "trial_title": "TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up"
      },
      {
        "id": "NCT01382225-sae",
        "title": "Sodium Hyaluronate vs Vehicle: serious adverse events",
        "summary": "1 of 723 against 1 of 727; risk difference 0.0 points, 95% interval -0.6 to 0.7; NCT01382225, Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome",
        "record": "/library/comparisons/NCT01382225-sae",
        "nct_id": "NCT01382225",
        "kind": "serious-adverse-events",
        "participants": 1450,
        "risk_difference": {
          "value": 0.000007610046021753374,
          "lower": -0.00646775365287758,
          "upper": 0.006516369677479039
        },
        "group_1": "1 of 723",
        "group_2": "1 of 727",
        "difference": "0.0 points",
        "interval": "-0.6 to 0.7",
        "trial_title": "Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=221",
  "request_id": "IseCeZiRRmT7eCL1"
}